(Q55078672)

17 June 2018

title

Mapping of melanoma modifier loci in RET transgenic mice. (English)

1 reference

17 June 2018

author name string

T A Dragani

1

1 reference

17 June 2018

B Peissel

2

1 reference

17 June 2018

N Zanesi

3

1 reference

17 June 2018

A Aloisi

4

1 reference

17 June 2018

Y Dai

5

1 reference

17 June 2018

M Kato

6

1 reference

17 June 2018

H Suzuki

7

1 reference

17 June 2018

I Nakashima

8

1 reference

17 June 2018

publication date

1 November 2000

1 reference

17 June 2018

number of pages

6

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

17 June 2018

volume

91

1 reference

17 June 2018

issue

11

1 reference

17 June 2018

page(s)

1142-1147

1 reference

17 June 2018

Linkage disequilibrium and physical mapping of Pas1 in mice

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Cancer resistance genes in mice: models for the study of tumour modifiers

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

The role of the ret proto-oncogene in human disease

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Mapping of body weight loci on mouse chromosome X.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Genetics of chemical carcinogenesis. 1. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.

18 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Role of the INK4a locus in tumor suppression and cell mortality.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926280

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

13 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2000.TB00897.X

Linkage disequilibrium and haplotype mapping of a skin cancer susceptibility locus in outbred mice.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2000.TB00897.X

Transgenic mouse model for skin malignant melanoma

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells

1 reference

12 December 2020

Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma

1 reference

12 December 2020

c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype

1 reference

12 December 2020

10.1111/J.1349-7006.2000.TB00897.X

Identifiers

DOI

1 reference

17 June 2018

PMCID

5926280

1 reference

17 June 2018

PubMed ID

11092979

1 reference

17 June 2018